Translate to...

Drug regulator okays psoriasis injection for limited use in treating COVID-19 patients

Drug regulator okays psoriasis injection for limited use in treating COVID-19 patients

Drug regulator okays psoriasis injection for limited use in treating COVID-19 patients Considering the unmet medical needs to treat COVID-19, Drugs Controller General of India Dr V G Somani approved monoclonal antibody injection Itolizumab for restricted emergency use for the treatment of #39;cytokine#39; release syndrome in moderate to severe acute respiratory distress syndrome patients due to COVID-19, they said on Friday.